-+ 0.00%
-+ 0.00%
-+ 0.00%

Chicago-Based Cannabis Giant Cresco Labs Loss Widens On $61 Million Charge For Taxes -- MarketWatch

MarketWatch·08/08/2024 12:02:00
Listen to the news

Cresco Labs Inc. (CRLBF) (CA:CL) said Thursday its second-quarter loss widened on a $61 million charge related to its tax position, as revenue remained about flat. Cresco Labs said it lost $51.18 million in the quarter, after losing $2.06 million in the year-ago period. The company did not provide figures for loss per share. Second-quarter revenue edged up to $184.36 million from $184.3 million in the year-ago period, and came in below the FactSet consensus estimate of $184.8 million. Cresco Labs said it expects to recognize $65 million in cash savings in 2024 based on its projected tax impact, but it took the $61 million charge to cover its tax position. If the federal government lowers the classification of cannabis to Schedule III as proposed, the 280E tax rules that prohibit cannabis companies from taking standard business deductions would no longer apply. Cresco Labs' stock is up 6.7% so far in 2024, compared to a 5.4% drop by the AdvisorShares Pure U.S. Cannabis EFT (MSOS).

-Steve Gelsi

For more from MarketWatch: http://www.marketwatch.com/newsviewer

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

August 08, 2024 08:02 ET (12:02 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.